N-Cyclopropyl-N-(1-{[3-(dimethylamino)phenyl]carbonyl}-piperidin-4-yl)-3-(trifluoromethyl)benzenesulfonamide

ID: ALA2180898

PubChem CID: 71457386

Max Phase: Preclinical

Molecular Formula: C24H28F3N3O3S

Molecular Weight: 495.57

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CN(C)c1cccc(C(=O)N2CCC(N(C3CC3)S(=O)(=O)c3cccc(C(F)(F)F)c3)CC2)c1

Standard InChI:  InChI=1S/C24H28F3N3O3S/c1-28(2)21-7-3-5-17(15-21)23(31)29-13-11-20(12-14-29)30(19-9-10-19)34(32,33)22-8-4-6-18(16-22)24(25,26)27/h3-8,15-16,19-20H,9-14H2,1-2H3

Standard InChI Key:  GYBZUPQPAFWYHB-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 34 37  0  0  0  0  0  0  0  0999 V2000
    8.2872  -20.7868    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    7.5713  -20.3744    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.4279  -21.6118    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1438  -22.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8597  -21.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.8597  -20.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1438  -20.3744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4279  -20.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7162  -22.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.7162  -22.8493    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.0003  -21.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.0003  -20.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2845  -20.3744    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5728  -20.7868    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5728  -21.6118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2845  -22.0243    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.5713  -19.5494    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9838  -18.8336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1588  -18.8336    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0013  -20.3738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7122  -20.7882    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4259  -20.3758    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4256  -19.5499    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7058  -19.1382    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9950  -19.5530    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1404  -20.7880    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1407  -21.6130    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8548  -20.3753    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.8498  -21.1997    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.8666  -21.4956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.6916  -21.4956    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8580  -22.0237    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.1439  -21.6106    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8573  -22.8487    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  7  1  0
  7  8  1  0
  3  8  1  0
  9 10  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
  9 11  1  0
  3  9  1  0
  2  6  1  0
 17 18  1  0
 18 19  1  0
 17 19  1  0
  2 17  1  0
  1 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  2  0
 25 20  1  0
 22 26  1  0
 26 27  1  0
 26 28  1  0
 26 29  1  0
  1 30  2  0
  1 31  2  0
 15 32  1  0
 32 33  1  0
 32 34  1  0
M  END

Associated Targets(Human)

CACNA1C Tclin Voltage-gated L-type calcium channel alpha-1C subunit (766 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCNH2 Tclin HERG (29587 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CACNA1B Tclin Voltage-gated N-type calcium channel alpha-1B subunit (743 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.57Molecular Weight (Monoisotopic): 495.1803AlogP: 4.23#Rotatable Bonds: 6
Polar Surface Area: 60.93Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.73CX LogP: 3.59CX LogD: 3.59
Aromatic Rings: 2Heavy Atoms: 34QED Weighted: 0.60Np Likeness Score: -1.85

References

1. Shao PP, Ye F, Chakravarty PK, Varughese DJ, Herrington JB, Dai G, Bugianesi RM, Haedo RJ, Swensen AM, Warren VA, Smith MM, Garcia ML, McManus OB, Lyons KA, Li X, Green M, Jochnowitz N, McGowan E, Mistry S, Sun SY, Abbadie C, Kaczorowski GJ, Duffy JL..  (2012)  Aminopiperidine sulfonamide Cav2.2 channel inhibitors for the treatment of chronic pain.,  55  (22): [PMID:23098566] [10.1021/jm301056k]

Source